BioNTech SE BNTX
NASDAQ BNTX
$96.90 +0.05 (+0.05%)
At close: Oct 2, 2026 · 4:00 PM EDT

BioNTech SE (BNTX) Income from Non-Controlling Interests (2018 - 2021)

Updated

BioNTech SE's Income from Non-Controlling Interests came in at $3.62 billion for Q4 2021, up 728.0% from $437.45 million a year earlier.

Analysis

BioNTech SE (BNTX) Income from Non-Controlling Interests (2018 - 2021) Analysis & Trends

Over the trailing twelve months to Dec 31, 2021, BioNTech SE reported Income from Non-Controlling Interests of $4.06 billion, up 828.0% year-over-year; for FY2019, it came in at -$111,993.

  • Going back by year, Income from Non-Controlling Interests was -$287,063 in FY2018 and -$335,411 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -2.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -7.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 1.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 10.00 Mn
10 BioNTech SE 24.50 Bn -34.86 Bn 10.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 3.62 Bn
Dec 31, 2020 437.45 Mn
Dec 31, 2019 17,710.20
Mar 31, 2019 -131,848.95
Dec 31, 2018 -138,108.97
Sep 30, 2018 -54,667.07
API Access

BioNTech SE Income from Non-Controlling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=BNTX&period=max&api_key=YOUR_API_KEY